News

FDA approves pembrolizumab for resectable head and neck cancer with PD-L1 expression
Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...
Scientists develop a foundational map of tumor cells for personalized brain cancer treatments
City of Hope researchers have co-led the first study to demonstrate that characterizing genetic material near chromosomes ...
The Lancet3d
Lurbinectedin with atezolizumab maintenance therapy in extensive-stage small-cell lung cancer
Small-cell lung cancer (SCLC) is one of the most lethal cancers, with patients diagnosed with extensive-stage small-cell lung cancer (ES-SCLC) experiencing a median survival of just 12 months after ...
The Lancet3d
Lung cancer
This seminar provides an overview of advances in the screening, diagnosis, and treatment of non-small-cell lung cancer and small ... nodes and occult distant metastases in patients who might otherwise ...
Cancer Research UK5d
A trial of apatorsen and chemotherapy for non small cell lung cancer that has spread
The Hsp27 protein can help cancer cells to protect themselves from cancer treatment. Hsp27 is only found in some types of lung cancer. The doctors in this trial think that by blocking Hsp27, or ...